Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
DOJ Announces $2.2 Billion in 2020 FCA Recoveries and Identifies 2021 Priorities
Fourth Circuit Finds Defendants Flagrantly Disregarded Repeated Legal Advice About Illegality of Sales Commissions for Blood Test Services; United States Court of Appeals for the Fourth Circuit No. 18-1811, U.S. ex rel. Scarlett Lutz v. LaTonya Mallory, et al.
Court Mostly Grants Relator’s Motion to Compel Discovery in Pratt & Whitney Fraud Case; U.S. District Court for the District of Connecticut No. 3:16-CV-1730 (AVC), United States ex rel. Peter J. Bonzani Jr. v. United Technologies Corporation, et al.
Managing the Next Big False Claims Act Whistleblower: Your Data
U.S. Supreme Court Declines to Clarify False Claims Act Falsity Standard
Déjà Vu All Over Again: Pandemic Renews Focus on Ongoing False Claims Act Enforcement Priorities
Grassley Letter to AG Nominee Garland Previews Legislation To Curtail DOJ Dismissal Authority and Materiality Requirement
Court Declines to Extend SCOTUS Allina Decision to FCA Context; United States District Court for the Northern District of Mississippi, Oxford Division, No. 3:15-CV-000127-MPM-JMV, U.S. ex rel. Kevin Gray v. Mitias Orthopaedics PLLC and Hanna Mitias M.D.
Condition of Participation in Medicare Not the Same as Condition of Payment; United States District Court for the District of Hawaii No. 19-00101 JMS-RT, U.S. ex rel. Lisa Torricer v. Liberty Dialysis-Hawaii LLC, et al.
GAO’s High Risk List Puts Spotlight on Emergency Loans For Small Businesses, Reinforcing Audit and Investigation Risk for PPP and EIDL Program Participants
DOJ Fraud Section 2020 Year in Review: Money Laundering Statute Remains an Overseas Enforcement Tool
FCA Insider Blog Interview with Michael Podberesky: Part II
MoForecast Podcast: Predictions on the False Claims Act
Directed Donations to Fund Covering Patient Copays May Have Induced Physicians to Prescribe Defendant’s Medication; United States District Court for the District of Massachusetts No. 20-11217-FDS, U.S. v. Regeneron Pharmaceuticals Inc.
Failure to Respond to DOJ Veto Motion Converts Dismissal Into Adjudication on the Merits; United States District Court for the Northern District of Illinois, Eastern Division, No. 19 C 7247, State of Illinois ex rel. Byron Strakusek v. Omnicare Inc. and CVS Health Corporation
Medicare Advantage Providers Be Aware: Choppy Enforcement Waters Ahead
Provider Beware: Recent FCA Cases Emphasize the Importance of Diligently Addressing Potential Overpayments
DOJ Gives the First Glimpse Into FCA Enforcement Priorities Under the Biden Administration—Some Expected, Others Less So
Relator Cannot Maintain Dismissed Qui Tam Action Under Seal, District Court Rules
Keep reading
